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Abstract: This article describes a complete prototype system that can be used in electrotherapy treatments, that is, in 
medical treatments involving electric currents. The system is composed of  two main blocks: the master and the slave. The 
Master block, whose main component is a CPU, controls the user interface. The Slave block, which is composed of a mi-
crocontroller and a wave generator, produces the appropriated voltages and currents compatible with the desired treat-
ment. The whole system is powered by a 12 V power supply and the output signal voltage ranges between -100 V and 
100 V. Despite the prototype being able of performing all the electrotherapy treatments in the low-medium frequency 
ranges, it was tested in aesthetic mesotherapy, namely in anticellulite, located anticellulite, antistretch, and antiflaccidity. 
In these treatments, the output signal is composed of an   overlap of two frequencies: the first one is selected in the range 
of 1.2 kHz - 1.8 kHz and the second   in the range of 0.07 Hz - 2 Hz. The system was tested in a clinical environment with 
real patients. It showed good results both in effectiveness of treatments and in terms of pain suffered by the patients. 
Keywords: Electrotherapy, Mesotherapy. 
INTRODUCTION 
 Electrotherapy is now commonly used in medicine. The 
process involves no pain and it is very effective in some 
diseases, so it has a wide range of applications [1, 2]. Cranial 
electrotherapy stimulation (CES) is a noninvasive procedure 
that has been used for decades to treat anxiety, depression, 
and insomnia in the general population [3, 4]. Additionally, 
in vivo studies were conducted to quantify the effectiveness 
of low-level direct electric current for the treatment of differ-
ent types of tumors and certain types of cancer [5, 6].  
 The main method for pain management is medication. 
Another very different approach is the application of electric 
currents in the range of μA to mA, to specific areas of the 
head. While this may sound like a novel concept to most of 
us, years of research indicate that transcranial electrotherapy 
stimulation (TES) can work to noninvasively increase the 
release of endogenous opioids from pain management re-
gions of the brain [7-9]. 
 Recently, electrotherapy has been used in muscular pain 
treatment, [8], muscular spasms [9], infections, arthritis, hair 
loss, rheumatic diseases [10], anxiety control, acne, weight 
loss [11], stretch marks treatments [12], cellulite treatments, 
and skin rejuvenation [13, 14]. 
 The protocols or treatments that this stimulator prototype 
is capable of generating embrace both low and medium fre-
quencies of the electrotherapy spectrum [15]. The main 
groups of available treatments are shown in Table 1. When 
properly organized, the number of available treatments 
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Note: Classical and recently proposed treatments were combined. It is 
possible to obtain 26 different protocols as a whole. 
*TENS: Transcutaneous Electrical Nerve Stimulation 
 
totalizes 26; 12 of which are programmable and 14 fixed. In 
programmable treatments, parameters like current, waveform 
or frequency can be altered by the operator over a wide range 
of values. For fixed protocols, current control is usually the 
only one necessary. Treatments are also different according 
to their electrical stimulus patterns and to the physiological 
effects they produce. Such effects can be extremely diverse 
for different configurations of a particular protocol [10]. 
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 This project was funded by a company, whose main goal 
was to develop a hardware prototype capable of performing 
aesthetic mesotherapy, reducing the technical expertise 
needed in treatment handling. On the other hand, since the 
prototype was designed to perform all low and medium fre-
quency electrotherapy treatments, it is possible to expand its 
functionalities simply by upgrading software. Thus, despite 
the development of this prototype being targeted for aes-
thetic medicine, it can also achieve other types of treatments 
since the platform accepts other signals by changing only a 
few setup parameters. 
 Electronic devices applied to medicine must have precise 
accuracy and reliability factors. In particularly those in direct 
contact with the patient which leaves no room for error. In 
the past, all the options taken in the development of these 
devices were mainly related to the choice of materials and 
methods that used to maximize perfection, quality, reliabil-
ity, and performance. In order to achieve the best results 
during a treatment, the equipment must guarantee  clear and 
precise signal output with  perfect repetition and very low 
error tolerance (below 1%).  
 As the main goal of the project was to develop a proto-
type to be used in aesthetic mesotherapy, we will focus our 
description in this area, despite the fact that the prototype can 
perform other electrotherapy treatments. In the aesthetic 
medicine area there are different types of treatments which 
can be seen as a resource of mesotherapy, namely: 
 Anti-cellulite; 
 Located anti-cellulite; 
 Anti-stretch; 
 Anti-flaccidity. 
 Each type of treatment needs a signal with single polar-
ity, that is, the output current ranges between zero and a 
maximum value, selected by the operator. In all the treat-
ments the applied signals obeyed to: 
  )()().()( tLFtLFtHFtV   (1) 
where V(t) is the output voltage, HF(t) is the  high frequency 
waveform component, whose value ranges between 1.2 kHz 
and 1.8 kHz, and LF(t) is the low frequency waveform com-
ponent, whose frequency ranges from 0.07 Hz to 2 Hz, that 
is, its period ranges between 0.5 and 14 seconds. Notice that 
V(t) must always be positive. If equation (1) gives a negative 
value, for a given t, the output is set to zero. Fig. (1) shows a 
waveform representation. 
 Finally, the fact that some drugs only work with negative 
currents must also be considered. In this case, everything that 
was said in the preceding paragraphs is true, except that the 
current direction must be reversed for such drugs. This is 
done by ranging the voltage between a minimum negative 
























Fig. (2). Output waveform of a mesotherapy treatment using negative-polarity drugs. 
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METHODS 
 The main objective of this project is the development of a 
device prototype capable of performing electrotherapy 
treatments at low and medium frequency as referred above. 
In order to do so, the following characteristics must be taken 
into account: 
 The programmable signal generator must be able of 
producing signals with frequencies up to 10 kHz. 
 Due to practical issues, the system supply voltage can-
not exceed 12 V, while the output signal may contain 
peaks that reach 100 V; 
 The setup must have appropriate safeguards to avoid 
patient injuries; 
 The user interface must be friendly, in order to be used 
by technical personal without expertise in  electronics 
and computing; 
 The setup must be flexible enough to allow for the in-
troduction  of  new types of treatments without hard-
ware upgrades; 
 The setup must perform self diagnosis tests and report 
any type of anomaly; 
 The setup must be able to work 24 h a day, 7 days a 
week. 
 The general system architecture proposed in this article is 
a master-slave structure since there are two control units: the 
high-level one (master) and a low-level one (slave). 
 The high-level control unit, central processing unit 
(CPU) or simply the master is responsible for supporting the 
user interface, exchanging and processing the necessary 
information between the user and the low-level control unit. 
The low-level control unit or slave is responsible for convert-
ing digital data, sent by the high-level control unit, to analog 
signals, which are directly applied to the patient. Its main 
component is a microcontroller. The low-level control unit, 
once programmed with a treatment data, can operate alone. 
Nevertheless, it may be useful to maintain the high-level 
control unit connected for debugging, treatment monitoring 
and error or malfunction detection. Fig. (3) shows the system 
architecture. 
 The Master block is composed of a processor unit, a 
touch screen and an Ethernet interface, while the Slave block 
is made up of a microcontroller, a driver, a step-up DC - DC 
converter, a H-bridge, a filter and the patient’s protection 
circuit. Both master and slave blocks communicate between 
themselves by means of a USB interface. Fig. (4) shows the 
block diagram of the whole system. 
 The CPU is the head of the system. It is responsible for 
gathering all the data that comes from the user interface 
console, processing it and calculating the appropriated coef-
ficient vectors that will be used by the microcontroller to 
produce the corresponding output signal. 
 If we consider that the technical personal do not have 
expertise in computing and electronic technologies, it is 
important to provide an intuitive graphical interface. For this 
purpose, a touch-screen monitor was used to operate the 
device. The programming language used was C++, associ-
ated to an Open GL platform in order to satisfy several re-
quirements, namely the real time operation, the support for 
microcontroller systems and achieving the system’s maxi-
mum graphic potential. The software was designed for a set 
of specific treatments where the operator does not need to 
change the characteristics of the electrical signals, except for 
the maximum amplitude that can change from patient to 
patient. Nevertheless, it allows for new signals to be pro-
grammed by a specialized technician. It is important to point 
out that this platform is based on a Linux operating system; 
due to its great potential for real time operation associated 
with the advantage that it being free software, making it 
easier and cheaper to commercialize the system. 
 Another particular feature is the system’s versatility, 
which allows firmware upgrades and interconnection with 
other devices by the Ethernet interface, in order to allow a 
huge range of treatments. 
 The interface between master and slave units is achieved 
by means of a USB connection due to its large bandwidth 
and plug-and-play interoperability. A full-duplex low speed 
(1.5 Mbit/s) data rate connection is used, which guarantees 
up to 512 kbit/s of bandwidth in each direction. The Bus 
topology used is the Reduced Host Topology which has a 
unique USB port and does not handle full USB tree with 
hub. This means that a reduced host controller is designed to 
handle a unique point-to-point connection with a unique 
USB device. 
 All interconnections between CPU and other functional 
blocks are bidirectional, allowing a continuous feedback that 
enables instantaneous detection of any anomaly. 
 The low level control unit main block is a microcontrol-
ler which is responsible for assembling the information sent 
by the CPU, in order to drive the H-Bridge. It calculates the 
PWM (Pulse Width Modulation) ON / OFF times, generat-









Fig. (3). System architecture. The CPU operates as master and the microcontroller operates as a slave. The microcontroller functionalities are 
programmed by the CPU and then, the microcontroller can run alone. 
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ate signals with frequencies up to 10 kHz, the sampling fre-
quency used in the microcontroller is about 50 times higher 
than the output signal frequency to ensure a low ripple at the 
filter output. In order to achieve that, an 8 MHz crystal was 
used. The microcontroller was the AT90USB1287, which is 
a low-power CMOS 8-bit unit, based on AVR with 64/128K 
bytes of ISP Flash, a USB device controller with full speed 
and low speed data transfer support and an enhanced RISC 
architecture. By executing powerful instructions in a single 
clock cycle, the AT90USB1287 achieves throughputs ap-
proaching 1 MIPS per MHz allowing the system designer to 
optimize power consumption versus processing speed. 
 The microcontroller output signal produces a peak volt-
age of 3.3V. To manage an effective treatment it is necessary 
to amplify this signal to higher levels, which can reach 
100 V, depending on the treatment. To carry out this task, an 
H-bridge with two quadrants was implemented, allowing the 
change of the signal output polarity according to the corre-
sponding treatment. The H-Bridge was implemented by 
means of the STMicroelectronics chip L6225, which is a 
DMOS Dual Full Bridge device that combines isolated 
DMOS Power Transistors with CMOS and bipolar circuits 
on the same chip. Fig. (5) shows the schematic diagram of 
the driver and the H-bridge. 
 Standard requirements imposed on medical equipment do 
not allow power systems, responsible for generating treat-
ment signals, to have input voltages higher than 12 V. Nev-
ertheless, to obtain the expected results, the signal output 
must produce peaks up to 100 V. This is achieved by means 
of a step-up DC to DC converter circuit, which provides up 
to 100 V with small ripple and 500 mA of maximum output 
current. In this application, the current will not exceed 
50 mA. The step-up DC to DC converter circuit is imple-
mented with the Linear Technology LT1680 device. The 
schematic diagram of the converter is shown in Fig. (6). 
 The filter block of Fig. (4) is responsible for the decrease 
of the ripple generated by the PWM to accepted levels. It is a 
second order low-pass LC filter, with a cut-off frequency of 
10 kHz. Fig. (7) shows the schematic diagram of the filter. 

































where  CLfo 2/1 ,  CRCLQ /  and R is the resis-
tance of the coil. The cut-off frequency of 10 kHz can be 
achieved by making L = 2.5 mH and C = 100 nF. 
 All equipment must comply to safety rules imposed by 
responsible entities. Therefore, in addition to the main objec-
tive, that is, the electrotherapy equipment, we must also 
ensure the safety of the patient. In so doing, a current limiter 
was introduced in the signal output. When the current 
reaches values above 30 mA, the output voltage of the circuit 
is lowered. Fig. (8) shows the output voltage waveform as a 
function of the current. This current limitation is imple-
mented by the microcontroller through the feedback loop, 
that is, the output voltage is feed back to the microcontroller 
by means of an ADC (analog to digital converter). This 
feedback loop also allows the monitoring of the output volt-





















Fig. (4). Block Diagram of the device internal structure and the links between the various sub-systems.  
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 Fig. (9) shows the block diagram of the master software 
algorithm. The master operation starts by waiting for the user 
instructions. After that, it processes the user instructions and 
sends the appropriate commands to the slave. The program 
then enters a loop controlled by a timer. Inside this loop the 
master only overlooks the slave activity. When the treatment 
time is achieved or in an error condition, the program leaves 
the loop, it sends a switch-off order to the slave, and waits 
for new user instructions. 
 Fig. (10) shows the block diagram of the slave software 
algorithm. It consists of four independent subroutines, each 
one activated by an interrupt state. 
 The first subroutine is activated when data is available at 
















Fig. (5). Driver circuit and H-Bridge circuit. They are based on BCD technology. Combines isolated DMOS Power Transistors with CMOS 













Fig. (6). Step-Up circuit. High power, current mode switching power supply controller optimized for boost topologies. The IC drives an N-





Fig. (7). Second order low-pass filter with cut-off frequency of 10 kHz. 
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processes it and generates an appropriate interrupt condition 
in order to activate one of the other three subroutines. The 
appropriate interrupt conditions are: treatment processing, 
treatment state and end of treatment. 
 The second subroutine is activated by the treatment proc-
essing interrupt. It starts by initializing the timer. Then, it 
enters a loop controlled by the same timer. Inside the loop, 
the output voltage is updated by reprogramming the PWM 
controller. 
 The third subroutine is activated by the treatment state 
interrupt. This interrupt is activated by two events: by the 
master, asking for feedback; and in a timer-controlled event, 
that implements the protection feedback loop described 
above. When this subroutine is activated, it only reads the 
output voltage value and sends it to the master. 
 The fourth subroutine is activated by the end of treatment 
interrupt. When this interrupt is activated, the microcontrol-
ler switches-off all the power devices and resets all the inter-
nal variables. 
 Fig. (11) shows two pictures of the prototype. 
EXPERIMENTAL PROCEDURE AND RESULTS 
 The signal output is a sum of two components: a low 
frequency of 0.07 Hz (Period = 14 s) and a high frequency of 
1.8 kHz. The filter eliminates the high frequency compo-





Fig. (8). Output voltage versus current. For currents above 30mA the system protection responds by reducing the output voltage. Vp is the 




















Fig. (9). Block diagram of the master algorithm. 
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tions are smoothed. Fig. (12) shows the system output wave-
form and Fig. (13) shows a detail of the waveform of Fig. 
(12) for only 5 periods of the PWM wave, that is, for 10 μs. 
In this figure, it is possible to observe that the ripple has 
11 mV of amplitude and do not influence the treatments. 
 Fig. (14) shows the output waveform of the anti-cellulite 
program at 40% of full power.  
 Another aspect that was tested with real patients is the 
risk of skin burn. The tests showed that the greater risk oc-










































Fig. (10). Block diagram of the slave algorithm. 
  
Fig. (11). Prototype internal circuits and external appearance. 
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is substantially decreased if some of the following rules are 
applied: 
 The electrodes must be very carefully applied to the 
skin, in order to avoid hot spots, 
 Electrodes must be frequently and deeply  moistened in 
order to increase electrical and thermal conductivity, 
 The DC current must be switched on with a slow in-
crease of intensity. 
 When these rules are followed, the patients feel a very 
reduced pricking or nothing at all. 
 The prototype was tested in a clinical environment, with 
real patients. The results of these tests are subjective and 
consist of the opinion of the technicians and patients. When 
asked about the effectiveness of the treatment, their answers 
were mainly “good” and “very good”. When asked about 
filling pain, the answers were “no pain” and “a little prick-
ing”. 
CONCLUSIONS 
 This article described a complete system prototype for 
use in low and medium frequency electrotherapy. The sys-
tem is composed of a master-slave architecture in which the 
master block is based on a CPU and the slave block is based 
on a microcontroller. The first system prototype dedicated to 
the aesthetic mesotherapy, has already been manufactured 
and tested in laboratory conditions with performances that 
have corresponded to those expected.. It was also tested in a 
clinical environment, with real patients. The results of these 
tests are more or less subjective since they consist of the 
opinion of the technicians and patients, but almost every one 
considered the performance of the prototype as good or very 
good. 
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